Commercialising orphan drugs: the pharmaphorum podcastIn episode 4 of the podcast pharmaphorum talked to Dr Joe Wiley, CEO of UK-based biopharmaceutical company Amryt Share XCommercialising orphan drugs: the pharmaphorum podcasthttps://pharmaphorum.com/r-d/views-analysis-r-d/orphan-drugs-pharmaphorum-podcast/
The future biosimilar landscape: the pharmaphorum podcastFor episode 3 of the pharmaphorum podcast Dominic Tyer went to the UK headquarters of Sandoz to meet Share XThe future biosimilar landscape: the pharmaphorum podcasthttps://pharmaphorum.com/sales-marketing/the-future-biosimilar-landscape/
MULTICHANNEL EFFECTIVENESS FOR PHARMAWilliams Lea Tag Customer Engagement: Five trends to improve your campaign marketing Most industries are adopting multichannel marketing Share XMULTICHANNEL EFFECTIVENESS FOR PHARMAhttps://pharmaphorum.com/partner-content-sales-marketing/multi-channel-effectiveness-pharma/
“The important thing is to not stop questioning.” (Albert Einstein)Intuition and experience – the ideal combination for finding a solution to an issue… or is it? What Share X“The important thing is to not stop questioning.” (Albert Einstein)https://pharmaphorum.com/partner-content-sales-marketing/important-thing-not-stop-questioning-albert-einstein/
Understanding the Medical ContinuumBuilding a full picture of the development of a drug can be a time-consuming process. Data from multiple Share XUnderstanding the Medical Continuumhttps://pharmaphorum.com/partner-content-sales-marketing/understanding-medical-continuum/
Moving to the next stage in medical affairs: an analysis in melanoma immunotherapyWith an ever-growing array of new scientific data, medical affairs is evolving into its 2.0 iteration. Now, the Share XMoving to the next stage in medical affairs: an analysis in melanoma immunotherapyhttps://pharmaphorum.com/views-and-analysis/moving-next-stage-medical-affairs-analysis-in-melanoma-immunotherapy/
Available on demand: Why the success of your HTA will rely on real world evidence This webinar is the first in a series of webinars focused on the topic: Unlocking the value; the Share XAvailable on demand: Why the success of your HTA will rely on real world evidencehttps://pharmaphorum.com/debates-insight-market-access/live-webinar-why-the-success-of-your-hta-will-rely-on-real-world-evidence/
Available on demand – Digital healthcare: be connected or be irrelevant So, we are finally at a point where with some certainty we can confirm we are in Share XAvailable on demand – Digital healthcare: be connected or be irrelevanthttps://pharmaphorum.com/audio/live-webinar-digital-healthcare-be-connected-or-be-irrelevant/
Wales’ life science hub: six months onpharmaphorum speaks to Dr Ian Barwick, chief operating officer of the Life Sciences Hub Wales, about where the Share XWales’ life science hub: six months onhttps://pharmaphorum.com/views-and-analysis/wales-life-science-hub-six-months-on/
